Vyant Bio, Inc. Common Stock
VYNT
VYNT was delisted on the 12th of May, 2023.
33 hedge funds and large institutions have $3.63M invested in Vyant Bio, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
14% more funds holding
Funds holding: 29 → 33 (+4)
3% more capital invested
Capital invested by funds: $3.52M → $3.63M (+$107K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$929K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$277K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$80.9K |
| 4 |
Renaissance Technologies
New York
|
+$68.5K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$42.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$149K |
| 2 |
SCA
Stonebridge Capital Advisors
St Paul,
Minnesota
|
-$57K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$34K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$31K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$25.3K |
VYNT Hedge Fund Activity: Q2 2016 in Review
33 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q2 2016, worth a combined $3.63M — up 3% from $3.52M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VYNT positions and 6 closed out — a net gain of 5 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was Perkins Capital Management, adding an estimated $929K. The largest seller was Bridger Management, exiting entirely with an estimated $149K sold.
- 33 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q2 2016, up from 29 in Q1 2016.
- Funds reported $3.63M of Vyant Bio, Inc. Common Stock stock for Q2 2016, up 3% quarter-over-quarter.
- 11 funds opened new Vyant Bio, Inc. Common Stock positions in Q2 2016 and 6 closed out, a net change of +5 holders.
- The largest Vyant Bio, Inc. Common Stock buyer in Q2 2016 was Perkins Capital Management, an estimated $929K added.
- The largest Vyant Bio, Inc. Common Stock seller in Q2 2016 was Bridger Management, an estimated $149K sold.
Based on aggregated 13F filings for Q2 2016.